Assessment of the $14.87 Billion Infusion Pumps Market 2026: Smart Infusion Pumps Drive Safer, Connected Care
Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Infusion Pumps Market by Device Type, Type of Usage, Type of Technology, Therapeutic Area, End User and Geographical Regions and Sales Forecast - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering.
The global infusion pumps market is projected to grow from USD 14.87 billion in 2026 to USD 25.39 billion by 2035, representing a compound annual growth rate (CAGR) of 6.1% during the forecast period. Increasing chronic disease prevalence, an expanding geriatric population and rising demand for precise medication administration are expected to support sustained market growth.
Infusion Pumps Market Growth and Trends
Demand for infusion pumps continues to increase as healthcare providers manage a growing number of patients with cancer, diabetes, cardiovascular disease, renal disorders and other long-term conditions. These diseases frequently require continuous or repeated medication delivery, strengthening the role of infusion systems across hospitals, ambulatory facilities and home-care environments.
The global infusion pumps market is also benefiting from the transition toward portable, wearable and implantable devices. These technologies support treatment beyond conventional hospital settings and align with the broader shift toward decentralized healthcare. Dose error reduction software, programmable drug libraries, occlusion alarms, air-in-line detection and low-reservoir alerts are further improving medication safety and treatment continuity.
Digital health integration is expected to remain a defining market trend through 2035. Artificial intelligence, Internet of Things connectivity, wireless data exchange and electronic health record interoperability are enabling real-time monitoring, remote pump management and data-driven clinical decisions. Manufacturers are increasingly developing integrated medication management platforms rather than relying solely on standalone infusion devices.
Key Market Drivers and Challenges
The growing incidence of chronic disease is a primary driver of infusion pump adoption. Demographic aging is creating additional demand for long-term treatment infrastructure, while home-based and ambulatory care models are accelerating the use of portable and wearable infusion pumps. Continuous product development, strategic partnerships and investment in connected care platforms are also encouraging healthcare organizations to replace legacy systems.
However, high acquisition costs may limit adoption of advanced smart infusion pumps in price-sensitive and resource-constrained markets. Manufacturers must also navigate stringent regulatory approval, quality management and post-market surveillance requirements. In addition, smart infusion systems require structured training for clinicians, caregivers and patients to support safe and effective operation.
Infusion Pumps Market Segment Highlights
Volumetric infusion pumps currently account for the largest share by device type and are expected to maintain their leadership through the forecast period. Their position is supported by widespread use in blood infusion, nutrient delivery, surgical fluid management and general medication administration. Wearable infusion pumps, however, are projected to record the highest CAGR as demand rises for continuous ambulatory therapy and connected home-care solutions.
Stationary infusion pumps represent the leading usage segment due to their extensive deployment in hospitals, intensive care units, ambulatory surgical centers and specialty clinics. These systems are commonly used for chemotherapy, intravenous fluids, antibiotics, parenteral nutrition, blood products and other high-risk medications requiring accurate flow control and continuous monitoring.
Smart infusion pumps hold the largest technology share and are also expected to experience rapid growth. Adoption is being supported by programmable drug libraries, dose error reduction systems, wireless connectivity, automated workflows and integration with electronic health records and hospital information systems.
Diabetes currently represents the largest therapeutic segment, driven by the growing use of wearable insulin pumps, continuous subcutaneous insulin infusion and continuous glucose monitoring-integrated delivery systems. Oncology is anticipated to register the highest CAGR through 2035 as infusion pumps become increasingly important for chemotherapy, immunotherapy, targeted treatments and supportive care.
Hospitals remain the largest end-user segment because of the high concentration of complex infusion procedures, trained clinical personnel and advanced treatment infrastructure. The home-care segment is expected to expand more quickly as remote patient monitoring, portable devices and decentralized treatment models gain wider acceptance.
Regional Market Outlook
North America is expected to remain the largest regional infusion pumps market through 2035. Its leadership is supported by established healthcare infrastructure, favorable reimbursement pathways, high adoption of advanced medical technologies and continued investment in connected medication management systems.
Asia-Pacific is projected to record the fastest regional growth. Healthcare infrastructure expansion, increasing diabetes and cancer prevalence, improving access to medical technologies and rising healthcare expenditure across emerging economies are creating significant opportunities for infusion pump manufacturers.
The report evaluates market opportunities across North America, Europe, Asia-Pacific and the rest of the world, with country-level analysis covering the US, Canada, Mexico, Germany, France, Italy, Spain, the UK, China, India, Japan and South Korea.
Competitive Landscape
The infusion pumps market remains moderately fragmented, with established manufacturers competing through product innovation, regulatory milestones, connected care investments and strategic collaborations. A selection of companies mentioned in this report includes, but is not limited to:
Recent developments include US Food and Drug Administration clearances for Baxter's Novum IQ large-volume infusion platform and ICU Medical's Plum Solo precision intravenous pump. Baxter has also continued to expand its Novum IQ and Spectrum IQ connected care platforms, while collaborations such as the National Infusion Collaborative between Bainbridge Health and B. Braun Medical demonstrate the growing importance of data-driven medication safety initiatives.
Report Scope and Market Segmentation
The infusion pumps market report provides revenue forecasts and opportunity analysis across the following segments:
The research also includes competitive benchmarking, company profiles, regulatory analysis, product competitiveness, startup ecosystem assessment, Porter's Five Forces analysis, value chain mapping, recent partnerships, funding activity, adjacent market opportunities and strategic recommendations. Case studies address infusion pump accessories and ambulatory infusion systems, including applications and product performance.
Key Reasons to Access the Report
The report includes complementary Excel data packs for analytical modules, up to 15% complimentary content customization, an in-depth walkthrough with the research team and a complimentary update when the purchased report is more than six months old.
For more information about this report visit https://www.researchandmarkets.com/r/l1gm5l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.